Fairvalue-Calculator Fairvalue-Calculator
EN DE

Sea Mild Biotechnology Co (7516) Fair Value & Analysis

Consumer Defensive · TW · Market cap 176M TWD

Price9.25 TWD
Fair Value9.15 TWD
Upside-1.1%
Quality95/100
Evidence: High Range 6.74 TWD – 11.44 TWD

Fair value as of: Jun 24, 2026

Analysis

Sea Mild Biotechnology Co (7516) currently trades at 9.25 TWD, while our model-based Fair Value estimate is 9.15 TWD — implying the stock looks roughly 1.1% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. The company was established in 2007 is headquartered in Taoyuan City, Taiwan.

Open the full interactive analysis →

Similar stocks

The Procter & Gamble Company (PG) -26% L'Oréal S.A (LRLCF) -54% Unilever PLC (UNLYF) -22% Colgate-Palmolive Company (CPA) -29% Hindustan Unilever Limited (HINDUNILVR) -68% Reckitt Benckiser Group (RBGLY) +41%

Frequently asked questions

Is Sea Mild Biotechnology Co (7516) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 9.15 TWD versus a price of 9.25 TWD — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 7516?
Our 21-model fair value for Sea Mild Biotechnology Co is 9.15 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 9.25 TWD.
What is the quality score of 7516?
Sea Mild Biotechnology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.